OXOMEMAZINE TEVA 0.33 mg/ml, syrup bottle, 150 ml
Active ingredients: Oxomemazine
Commercialized according to BDPM
Syrupbottle, 150 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OXOMEMAZINE TEVA 0,33 mg/ml, sirop
- Pharmaceutical form
- sirop
- Route of administration
- orale
- Presentation description
- flacon(s) en verre de 150 ml avec gobelet(s) doseur(s) polypropylène
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 15%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Sept 2010
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61336243CIP74926912CIP133400949269129Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| OXOMÉMAZINEsirop | 0,033 g · 100 ml de sirop | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.